This report from Life Science Intelligence provides the latest market data for the Global Transcatheter Mitral Heart Valves Market. Information covered by this report includes:
The global market for transcatheter mitral heart valve devices is expected to reach an estimated $843.5 million in 2020 and is projected to increase at a CAGR (2020-2024) of 41.1%. Product segments covered by this report include transcatheter mitral heart valves for mitral valve repair and replacement.
This report covers the impact of COVID-19 on the transcatheter mitral heart valves market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as Abbott, Medtronic, Edwards Lifesciences, Cardiac Dimensions, Mitralign, and others. The report provides insights into trends, drivers, and limiters of the transcatheter mitral heart valves market, as well as highlights potential opportunities.
The transcatheter mitral valve replacement market witnessed a minor decline due to the COVID-19 pandemic. The decline in procedures was very minimal and is expected to rebound by Q4 2020 and reach pre-COVID-19 levels in the first half of 2021.
The market for transcatheter mitral valve repair and replacement devices is robust, with numerous clinical trials ongoing and strong merger & acquisition activity as major competitors seek to bolster their structural heart portfolios. The high cost of the device and favorable reimbursement have made the segment extremely attractive for both small and large medtech companies.